Novelos Therapeutics
Novelos Therapeutics, Inc. (Novelos) is a biopharmaceutical company focused on developing and commercializing oxidized glutathione-based
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Novelos Therapeutics Information
Novelos Therapeutics was acquired by
Cellectar Biosciences.
The acquisition happend on 2011-04-12.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Madison
State: Wisconsin
Zip:
Country: United States
Financial Info
Stage:
post ipo equity
Raised Last:
$4M
Raised Total:$86M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Novelos Therapeutics, Inc. (Novelos) is a biopharmaceutical company focused on developing and commercializing oxidized glutathione-based compounds for the treatment of cancer and hepatitis. The Company&s;s compound, NOV-002 is a small-molecule compound based on a formulation of oxidized glutathione that has been administered to approximately 1,000 cancer patients in clinical trials. As of December 31, 2009, NOV-002 was in Phase II development for solid tumors in combination with chemotherapy. The Company&s;s second glutathione-based compound, NOV-205 acts as a hepatoprotective agent with immunomodulating and anti-inflammatory properties.
Contact Phone:
Contact Email:
Novelos Therapeutics went public on 6/14/2005 on the OTCBB
Listed Exchange:
OTCBB
IPO Date:
6/14/2005
Ticker Symbol:
NVLT
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2009 | Post-IPO Equity | $32.3M | 1/2010 | Convertible Note | 1 | $365k |
Advantage Capital Advantage Capital |
9/2009 | Post-IPO Equity | $3.5M | 6/2012 | Post-IPO Equity | $5.4M | 4/2007 | Post-IPO Equity | $15M | 4/2011 | Post-IPO Equity | $5.1M | 11/2009 | Post-IPO Equity | $9M | 2/2014 | Post-IPO Equity | $4M | 1/2011 | Post-IPO Equity | $11.2M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
